Design of Experiments to Achieve an Efficient Chitosan-Based DNA Vaccine Delivery System

Carlos Rodolfo1, Dalinda Eusébio1, Cathy Ventura1

  • 1CICS-UBI-Health Science Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.

Pharmaceutics
|September 28, 2021
PubMed

Insights

This study optimized chitosan/plasmid DNA nanosystems for DNA vaccines using design of experiments. Results show tailored nanoparticles with small size and high charge, advancing DNA vaccine delivery.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Vaccine Development

Background:

  • DNA vaccines offer a promising strategy for disease prevention and treatment, including viral infections and cancer.
  • Effective delivery of plasmid DNA (pDNA) is crucial for DNA vaccine efficacy.
  • Chitosan-based nanoparticles are explored as potential pDNA carriers due to their biocompatibility and mucoadhesive properties.

Purpose of the Study:

  • To optimize chitosan/pDNA nanosystems for enhanced DNA vaccine delivery.
  • To investigate the impact of chitosan molecular weight on nanoparticle characteristics.
  • To utilize design of experiments (DoE) for efficient formulation development.

Main Methods:

  • Formulation of chitosan/pDNA nanosystems via ionotropic gelation.
  • Application of DoE to systematically vary chitosan and TPP concentrations.
  • Analysis of nanoparticle size, polydispersity index (PDI), and zeta potential.
  • Evaluation of nanoparticle morphology, stability, and cytotoxicity.

Main Results:

  • Statistically significant models (p < 0.05) were obtained for optimizing nanosystem properties.
  • The smallest particle size (~82 nm) was achieved with 5 kDa chitosan.
  • The highest zeta potential (~+26.8 mV) was observed with high molecular weight (HMW) chitosan.
  • Nanosystems demonstrated stability over one month and no significant cytotoxicity.

Conclusions:

  • DoE is a powerful tool for tailoring chitosan/pDNA nanosystem characteristics.
  • Optimized nanosystems show potential as effective carriers for DNA vaccines.
  • Further in vitro studies are warranted to assess the full potential of these delivery systems.

Related Concept Videos